Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Science staff profile

 

Michelle Wilson

PositionLaboratory Technician
DepartmentDepartment of Pathology (DSM)

Publications

Zhang, J., Burn, C., Young, K., Wilson, M., Ly, K., Budhwani, M., Tschirley, A., Braithwaite, A., Baird, M., & Hibma, M. (2018). Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response. Scientific Reports, 8, 2373. doi: 10.1038/s41598-018-20779-2

Roth, I., Campbell, H., Rubio, C., Vennin, C., Wilson, M., Wiles, A., Williams, G., Woolley, A., … Fleming, N., Baird, M., & Braithwaite, A. W. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene, 35, 4981-4989. doi: 10.1038/onc.2016.45

Slatter, T. L., Wilson, M., Tang, C., Campbell, H. G., Ward, V. K., Young, V. L., … Fleming, N. I., Braithwaite, A. W., & Baird, M. A. (2016). Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12. OncoImmunology, 5(3), e1112941. doi: 10.1080/2162402X.2015.1112941

Slatter, T. L., Hung, N., Bowie, S., Campbell, H., Rubio, C., Speidel, D., Wilson, M., Baird, M., Royds, J. A., & Braithwaite, A. W. (2015). Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant. Cell Death & Disease, 6, e1783. doi: 10.1038/cddis.2015.149

Jemon, K., Young, V., Wilson, M., McKee, S., Ward, V., Baird, M., Young, S., & Hibma, M. (2013). An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy. PLoS ONE, 8(6), e66866. doi: 10.1371/journal.pone.0066866

Journal - Research Article

Zhang, J., Burn, C., Young, K., Wilson, M., Ly, K., Budhwani, M., Tschirley, A., Braithwaite, A., Baird, M., & Hibma, M. (2018). Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response. Scientific Reports, 8, 2373. doi: 10.1038/s41598-018-20779-2

Roth, I., Campbell, H., Rubio, C., Vennin, C., Wilson, M., Wiles, A., Williams, G., Woolley, A., … Fleming, N., Baird, M., & Braithwaite, A. W. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene, 35, 4981-4989. doi: 10.1038/onc.2016.45

Slatter, T. L., Wilson, M., Tang, C., Campbell, H. G., Ward, V. K., Young, V. L., … Fleming, N. I., Braithwaite, A. W., & Baird, M. A. (2016). Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12. OncoImmunology, 5(3), e1112941. doi: 10.1080/2162402X.2015.1112941

Slatter, T. L., Hung, N., Bowie, S., Campbell, H., Rubio, C., Speidel, D., Wilson, M., Baird, M., Royds, J. A., & Braithwaite, A. W. (2015). Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant. Cell Death & Disease, 6, e1783. doi: 10.1038/cddis.2015.149

Jemon, K., Young, V., Wilson, M., McKee, S., Ward, V., Baird, M., Young, S., & Hibma, M. (2013). An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy. PLoS ONE, 8(6), e66866. doi: 10.1371/journal.pone.0066866

Li, K., Peers-Adams, A., Win, S. J., Scullion, S., Wilson, M., Young, V. L., Jennings, P., Ward, V. K., Baird, M. A., & Young, S. L. (2013). Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo. Journal of Immunotherapy, 36(1), 11-19. doi: 10.1097/CJI.0b013e3182787f5e

Tang, R., Li, K., Wilson, M., Both, G. W., Taylor, J. A., & Young, S. L. (2012). Potent antietumor immunity in mice induced by vaccination with an ovine Atadenovirus vector. Journal of Immunotherapy, 35(1), 32-41. doi: 10.1097/CJI.0b013e318238a115

Sims, I. M., Frese, S. A., Walter, J., Loach, D., Wilson, M., Appleyard, K., … Livingston, M., Baird, M., Cook, G., & Tannock, G. W. (2011). Structure and functions of exopolysaccharide produced by gut commensal Lactobacillus reuteri 100-23. ISME Journal, 5(7), 1115-1124. doi: 10.1038/ismej.2010.201

Slatter, T. L., Hung, N., Campbell, H., Rubio, C., Mehta, R., Renshaw, P., Williams, G., Wilson, M., … Jeffs, A., Royds, J. A., Baird, M. A., & Braithwaite, A. W. (2011). Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform. Blood, 117(19), 5166-5177. doi: 10.1182/blood-2010-11-321851

Buchan, G. S., Lee, R., Wilson, M., Slobbe, L., Buddle, B. M., & Young, S. L. (2010). Strains of Mycobacterium avium differentially activate human dendritic cells. Immunology & Cell Biology, 88(1), 95-98. doi: 10.1038/icb.2009.51

Livingston, M., Loach, D., Wilson, M., Tannock, G. W., & Baird, M. (2010). Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunology & Cell Biology, 88(1), 99-102. doi: 10.1038/icb.2009.71

Slatter, T. L., Ganesan, P., Holzhauer, C., Mehta, R., Rubio, C., Williams, G., Wilson, M., Royds, J. A., Baird, M. A., & Braithwaite, A. W. (2010). p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death & Differentiation, 17, 540-550. doi: 10.1038/cdd.2009.136

Williman, J., Young, S., Buchan, G., Slobbe, L., Wilson, M., Pang, P., … Baird, M. (2008). DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Vaccine, 26, 5153-5158. doi: 10.1016/j.vaccine.2008.03.084

Young, S. L., Wilson, M., Wilson, S., Beagley, K. W., Ward, V., & Baird, M. A. (2006). Transcutaneous vaccination with virus-like particles. Vaccine, 24, 5406-5412. doi: 10.1016/j.vaccine.2006.03.052

Baird, M., Wilson, R., Young, L., Williman, J., Young, S. L., Wilson, M., Slobbe, L., Lockhart, E., & Buchan, G. S. (2004). Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens. Scandinavian Journal of Immunology, 60(4), 363-371.

Young, S. L., Buchan, G. S., Slobbe, L. J., Williman, J. A., Wilson, M., Ward, V. K., … Baird, M. A. (2004). Novel vaccine formulations to enhance type 1 immune responses. Immunology, 555-563.

Faulkner, L., Buchan, G. S., Slobbe, L., Lockhart, E., Wales, J. R., Wilson, M., & Baird, M. A. (2003). Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection. Vaccine, 21(9-10), 932-939.

Faulkner, L., Buchan, G., Lockhart, E., Slobbe, L., Wilson, M., & Baird, M. (2001). IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. International Immunology, 13(6), 713-721.

More publications...